Literature DB >> 19754754

The role of neutrophils in the development and outcome of zygomycosis in haematological patients.

L Pagano1, C G Valentini, L Fianchi, M Caira.   

Abstract

Zygomycosis constitutes the third leading cause of invasive fungal infections following aspergillosis and candidosis. Patients with haematologic malignancies or haematopoietic stem cell transplantation are particularly susceptible to zygomycosis. Neutropenia represents the most important pathogenic mechanism influencing the onset and outcome of zygomycosis. Neutrophils cause a lesion of the fungal wall with subsequent destruction by macrophages. They also enhance the activity of antifungal drugs against Zygomycetes. Strategies that aim to increase neutrophil count and function, such as granulocyte colony stimulating factor and granulocyte transfusion, could play an important role in the management of this life-threatening infectious complication.

Entities:  

Mesh:

Year:  2009        PMID: 19754754     DOI: 10.1111/j.1469-0691.2009.02977.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  8 in total

1.  Predisposing Factors for Mucormycosis in Patients with Diabetes Mellitus; An Experience of 21 Years in Southern Iran.

Authors:  Amene S Sarvestani; Gholamreza Pishdad; Shahram Bolandparvaz
Journal:  Bull Emerg Trauma       Date:  2013-10

Review 2.  Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species.

Authors:  Marisa Z R Gomes; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

3.  The Value of Metagenomic Next-Generation Sequencing in Hematological Malignancy Patients with Febrile Neutropenia After Empiric Antibiotic Treatment Failure.

Authors:  Meng Zhang; Zhao Wang; Jiaxi Wang; Hairong Lv; Xia Xiao; Wenyi Lu; Xin Jin; Juanxia Meng; Yedi Pu; MingFeng Zhao
Journal:  Infect Drug Resist       Date:  2022-07-07       Impact factor: 4.177

4.  Fatal-mixed cutaneous zygomycosis-aspergillosis: a case report.

Authors:  Estelle Cateau; Edouard Randriamalala; Antoine Elsendoorn; Jean-Philippe Giot; Christophe Monegier du Sorbier; Marie-Helene Rodier
Journal:  Mycopathologia       Date:  2013-10-02       Impact factor: 2.574

5.  Mucormycosis in renal transplant recipients: review of 174 reported cases.

Authors:  Yan Song; Jianjun Qiao; Gaffi Giovanni; Guangjun Liu; Hao Yang; Jianyong Wu; Jianghua Chen
Journal:  BMC Infect Dis       Date:  2017-04-18       Impact factor: 3.090

6.  Clinicopathological Study of Mucormycosis in COVID-19 Patients: Experience From a Tertiary Care Center in South India.

Authors:  Sangeetha Kandasamy; Srinivas Muthuraju; Arumugam Vasugi; Megala Chandrasekar; Roopmala Murugan; Poovizhi Inbasekaran; Prabu R
Journal:  Cureus       Date:  2022-03-10

7.  Purification and characterization of a cytochrome c with novel caspase-3 activation activity from the pathogenic fungus Rhizopus arrhizus.

Authors:  Manoj Saxena; Rohit Kumar Sharma; Josell Ramirez-Paz; Arthur D Tinoco; Kai Griebenow
Journal:  BMC Biochem       Date:  2015-09-03       Impact factor: 4.059

8.  Increased neutrophil percentage-to-albumin ratio is associated with all-cause mortality in patients with severe sepsis or septic shock.

Authors:  Yuqiang Gong; Diwen Li; Bihuan Cheng; Binyu Ying; Benji Wang
Journal:  Epidemiol Infect       Date:  2020-04-02       Impact factor: 2.451

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.